Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine

被引：2
|
作者：
Mei, Liyan [1 ]
Gao, Kaixin [1 ]
He, Xiaojuan [2 ]
Jakobsson, Per-Johan [3 ]
Huang, Runyue [1 ,4 ,5 ,6 ]
机构：
[1] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China
[2] China Acad Chinese Med Sci, Beijing, Peoples R China
[3] Karolinska Inst KI, Solna, Sweden
[4] Guangzhou Univ Chinese Med, Guangdong Hong Kong Macau Joint Lab Chinese Med &, Hong Kong, Guangdong, Peoples R China
[5] Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China
[6] Guangdong Prov Key Lab Clin Res Tradit Chinese Med, Guangzhou, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
disease-modifying antirheumatic drugs (DMARDs); traditional Chinese medicine (TCM); DMARDs-like effects; rheumatic diseases; new strategies; RHEUMATOID-ARTHRITIS; SAFETY;
D O I：
10.3389/fphar.2023.1135803
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs
    Marchesoni, Antonio
    Lubrano, Ennio
    Cauli, Alberto
    Ricci, Massimo
    Manara, Maria
    JOURNAL OF RHEUMATOLOGY, 2015, 42 : 61 - 64
  • [2] Disease-modifying antirheumatic drugs
    Lambert, David G.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2012, 13 (03) : 128 - 130
  • [3] Disease-Modifying Antirheumatic Drugs
    Brasington, Richard
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2009, 34A (02): : 347 - 348
  • [4] Disease-modifying antirheumatic drugs
    Lambert, David G.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2009, 10 (01) : 35 - 37
  • [5] Modern disease-modifying antirheumatic drugs
    Mueller-Ladner, U.
    Richter, K.
    Tarner, I. H.
    INTERNIST, 2015, 56 (03): : 307 - 314
  • [6] Disease-modifying antirheumatic drugs and organising pneumonia
    Faisal, Mohamed
    Roslan, Asyraf
    Abeed, Nik Nuratiqah Nik
    Ban Yu-Lin, Andrea
    BMJ CASE REPORTS, 2021, 14 (01)
  • [7] Risk profile of disease-modifying antirheumatic drugs: an update from the RABBIT register
    Albrecht, Katinka
    Strangfeld, Anja
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (15) : 998 - 1002
  • [8] Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine
    Mirkov, Masa Umicevic
    Coenen, Marieke J. H.
    PHARMACOGENOMICS, 2013, 14 (04) : 425 - 444
  • [9] Putting new disease-modifying antirheumatic drugs into perspective
    Saseen, Joseph J.
    PHARMACOTHERAPY, 2007, 27 (12): : 1609 - 1610
  • [10] Perinatal Use and Discontinuation of Disease-Modifying Antirheumatic Drugs
    Rebic, Nevena
    De Vera, Mary A.
    Gupta, Amit
    Amiri, Neda
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (05) : 188 - 192
12345